Inactive

The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to RESEARCH TRIANGLE INSTITUTE for the update and expansion to the CDC Online Diabetes Sta... The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to RESEARCH TRIANGLE INSTITUTE for the update and expansion to the CDC Online Diabetes State Economic Burden Toolkit. The mission of CDC/NCCDPHP is to reduce the burden of all chronic diseases including diabetes through the prevention and control of these diseases. Working with outside CDC partners is an important mean to achieve this mission. The Division of Diabetes Translation (DDT) has been working with State Health Departments (SHDs) across the nation to reduce the health and economic burdens associated with diabetes. Proving technical assistance to SHDS and data on heath burden of diabetes for their population is one of the important collaborative activities for DDT. From 2014 to 2016, working with RTI International, DDT developed a Diabetes State Economic Burden Toolkit. This toolkit provides state-age-sex specific data on diabetes-attributable economic cost consisting of medical (direct) costs, indirect costs, and costs from the perspective of State Medicaid programs, private insurers, and employers for each of the 50 states and District of Columbia. This user-friendly toolkit is based on rigorous science and best available state-level data. The toolkit was formally released for public use in 2017 (https://nccd.cdc.gov/Toolkit/DiabetesBurden/Home). The toolkit has been well received by the SHDs and general public since its release. For example, there are about 14,000 page views and over 6,000 visits annually. SHDs across all 50 states and DC use information obtained from the toolkit to assist their decsions related to program planning and evaluation on a regular base. Nearly all estimates in the toolkit were generated based on data in 2013, the latest available at the time of developing the toolkit. Based on its original design, the toolkit needs to be updated on a regular basis, such as every 5 years. However, the toolkit has not been updated since its release. Thus, estimates reported in the current toolkit are out of date and no longer reflect the current economic burden of diabetes for each state. Continuously using these data for program planning and evaluation could misguide SHDs decsions on efforts to reduce the burden of diabetes. More recent data to update the toolkit have become available. The primary objective of the project is to update the Diabetes State Economic Burden Toolkit, which includes the following outcome measures: total and per capita economic costs, total and per capita direct medical cost, total and per capita indirect costs, total and per capita medical costs by payer, total and per capita indirect cost by cost component (work absenteeism, work presenteeism, household productivity losses, and inability to work. total and per capita indirect cost by cost component (work absenteeism, work presenteeism, household productivity losses, and inability to work), total and per capita indirect cost by mortality status. For each measure, the toolkit reports the estimates in total, by age and by age/sex. The secondary objective is to add outcome measures or replace current outcome measures upon approval if they are found to be superior to the current measures and data that are available. The proposed study was to update and expand the Diabetes State Economic Burden Toolkit, which includes the following outcome measures: diabetes prevalence, diabetes incidence, diabetes-associated conditions, and mortality in total and by age-sex group. RTI International was the developer of the Diabetes State Economic Burden Toolkit. It has all expertise required to update and expand this toolkit including epidemiologists, statisticians, computer programmers. In addition, as the original developer, RTI knows all data and methods used to generate the estimate, the design and programming codes used for this online toolkit. RTI International as the original developer of the toolkit is identified as the only vendor that can meet all the research requirements of this complex toolkit and deliver the best value of money for the government. This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 10 U.S.C. 2304(c)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals. This notice of intent is not a request for competitive quotations; however, all quotations/responses received within fifteen (15) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist at qsx8@cdc.gov by COB 5pm Est, June 2, 2022